- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - Circassia Group Plc AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Farxiga approved in the US for CKD
AnnouncementREG - AstraZeneca PLC - AZN: First quarter 2021 results
AnnouncementREG - AstraZeneca PLC - Selumetinib recommended for EU approval in NF1
AnnouncementREG - AstraZeneca PLC - Tagrisso adjuvant receives positive CHMP opinion
AnnouncementREG - AstraZeneca PLC - Nirsevimab Phase III trial met primary endpoint
AnnouncementREG - AstraZeneca PLC - US clearance of proposed acquisition of Alexion
AnnouncementREG - AstraZeneca PLC - Tagrisso approved in China in early lung cancer
AnnouncementREG - AstraZeneca PLC - Circular and notice of general meeting
AnnouncementREG - AstraZeneca PLC - Update on Farxiga COVID-19 DARE-19 Phase III trial
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AZD1222 US Ph3 primary analysis confirms efficacy
AnnouncementREG - AstraZeneca PLC - AstraZeneca US vaccine trial met primary endpoint
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Divestment of Viela shareholding completed
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement